The Regulatory Information Management conference has brought together expert speakers and leaders in the field, providing a strategic overview of key RIM strategies and trends being deployed by industry. Also with IDMP gathering pace, the meeting has provided a full day dedicated to IDMP implementation.

Global eCTD Management conference has provided updates from European and international regulatory authorities and top industry speakers to ensure attendees have been up-to-date with latest developments and expectations.

Keynote Presentation

"Regulatory Information Management (RIM) vs. Master Data Management (MDM) – opportunities and challenges on the journey to data driven content automation"

Master Data Management (MDM) comprises the processes, governance, policies, standards and tools that consistently define and manage the critical data of an organization to provide a single point of reference. The objective of MDM is to provide a unique foundation for collecting, aggregating, matching, consolidating, quality-assuring, persisting, and distributing reliable data. As a consequence, MDM is a discipline for quality improvements supported by data governance processes and organizations. The ultimate goal being to provide the end user community with a "trusted single version of the truth" from which to base decisions.

Regulatory Information Management (RIM) is the business practice in the pharmaceutical industry involved in the development, capture, dissemination, control and management of regulatory-focused content, throughout all product lifecycle stages. RIM has been challenged by permanent changes of regulatory standards resulting in higher data delivery needs to agency, for instance by recent XEVMDP or ISO IDMP. On the one hand, the above definitions inherently substantiate a correlation, as proper Regulatory Information (RI) relies on proper Master Data (MD). On the other hand, RI can also become MD itself. The questions that arise are: how can boundaries and synergies be identified and utilized? What setups would allow mutual leveraging in order to positively impact business process designs to increase and sustain a company’s competitiveness and efficiency? 

Speaker: Romuald Braun (AMPLEXOR's VP Strategy, Life Sciences) 


Hotel Meliá Avenida América

Calle Juan Ignacio Luca de Tena, 36

28027 Madrid